Financial statements Remondis Medison
Cash inflows of REMONDIS MEDISON
Year
|
2020
|
2021
|
2022
|
2023
|
---|---|---|---|---|
Net cash from operating expenses | 7 459 771,10 | 23 877 473,24 | 8 741 043,03 | 19 664 404,65 |
Net cash flow from investing activities | 3 080 374,89 | -7 441 108,98 | 4 143 214,74 | -7 312 779,36 |
Net cash flow from financial activities | -9 738 675,83 | -14 233 304,13 | -12 270 073,91 | -14 385 602,57 |
Total net cash flow | 801 470,16 | 2 203 060,13 | 614 183,86 | -2 033 977,28 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.